ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

No reported Deferred Revenue figures are available to summarize.

Deferred Revenue history

Currency unavailable · from the balance sheet

No Deferred Revenue data reported for this period type.

Deferred Revenue vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Deferred Revenue for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PRQRProQR Therapeutics N.V.Mar 2026€19.63M EUR-5.6%—19.8%
STOKStoke Therapeutics, Inc.Mar 2026$10.07M USD-44.6%-7.2%2.3%
WVEWave Life Sciences Ltd.Mar 2026$9.4M USD-83.6%+12.1%1.6%
RNAAtrium Therapeutics, Inc.Mar 2026$9.34M USD——3.2%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$7.61M USD-49.6%-38.9%3.1%
PRMEPrime Medicine, Inc.Mar 2026$7.32M USD-10.9%—2.5%
MGTXMeiraGTx Holdings plcMar 2026$2M USD-52.9%-51.0%0.8%
SLNSilence Therapeutics plcMar 2026$0 USD-100.0%—0.0%
BNTCBenitec Biopharma Inc.Mar 2026$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-49.6%-23.0%2.3%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.